News
3 July 2009Novo Nordisk's Victozaź (liraglutide) receives marketing authorisation in Europe
28 June 2009Novo Nordisk insulin analogues have proven safety profiles
26 June 2009Novo Nordisk reaches settlement with the Danish authorities regarding Oil-for-Food activities
Latest financial releaseUpdate following publication of Diabetologia studies on insulin glargine
Novo Nordisk conference call Monday 29 June 2009 at 8 am CET (7 am GMT)
On Friday 26 June, Diabetologia, the journal of the European Association for the Study of Diabetes (EASD) published online data from four studies relating to a possible link between a long-acting insulin analogue, insulin glargine, and cancer.
To avoid unnecessary speculation about whether Novo Nordisk insulin analogues may be associated with an increased risk of cancer, Novo Nordisk hosts a conference call with a presentation of the safety profil for Novo Nordisk´s modern insulins in this regard followed by a Q&A session.
Click here to watch webcast
Calendar
| Date | Event | |
|---|---|---|
| 6 August 2009 | Financial statement for the first six months of 2009 | |
| 31 August 2009 | Sal. Oppenheim's 4th European Healthcare Investors Conference, Frankfurt | |
| 15 September 2009 | Morgan Stanley Global Healthcare Unplugged Conference, New York | |
| 15 September 2009 | Sanford C. Bernstein's annual Pan European Strategic decisions Conference, London | |
| 16 September 2009 | Nordea health care seminar, Stockholm |